Archivio Italiano di Urologia e Andrologia 2017; 89, 2146 SHORT COMMUNICATIONS Alprostadil plus Vacuum (VITARUM) in severe erectile dysfunction (ED) Franco Mantovani Clinica San Giovanni, Milan, Italy. Objectives: Severe erectile dysfunction (ED) is not uncommon, as can be seen from the epidemiological literature, and there are several possible causes, which are not always known, or leastways evident. Having ascertained the ineffectiveness, intolerance to or rejection of pharmacological aids, the option of pros- thetic surgery remains, but before this, it may be wise when feasible to use Alprostadil cream in association with Vacuum device. Material and methods: 12 patients, aged between 55 and 65 years, with severe erectile dysfunction without palpable cavernous fibrosis, were instructed to self-insert into the urethral meatus, 3 mg of Alprostadil cream, sufficient to make it easy to place the Vacuum device over the penis. Results: In the cases observed, the preliminary use of Alprostadil cream fast produced an erection with enough rigidity to place the Vacuum. A sufficient erection was maintained, obviously using an elastic ring at the base of the penis, to achieve penetration. The reproducibility of the use of Alprostadil cream with Vacuum device was then confirmed at home, to the satisfaction of the patients. KEY WORDS: Erectile dysfunction; Alprostadil cream; Vacuum device. Submitted 14 April 2017; Accepted 23 April 2017 Summary No conflict of interest declared. MATERIALS AND METHODS Twelve patients aged between 55 and 65 years, with severe erectile dysfunction scored between 15 and 20 by the International Index of Erectile Function (IIEF-15) index and an aetiology falling under the categories men- tioned above (but excluding palpable cavernosal fibrosis that was a criterium of exclusion for this treatment) (2), were instructed to self-insert into their own urethral meatus, 3 mg of Alprostadil, conveyed in a micro solu- tion gel with dodecyl dimethylammonium propionate (Vitaros). This patented natural surfactant technology allows for a rapid absorption of the drug, resulting in a penile turgid- ity, which is initially modest, but adequate to easily place the Vacuum device onto the penis avoiding repeated attempts. The Vacuum device is a tool of the andrological therapeutic armamentarium for many years. RESULTS In the cases observed, the preliminary turgidity obtained with Alprostadil cream (Vitaros) was soon followed by an erection produced by the Vacuum. A sufficient rigidity for penetration was maintained by using an elastic ring at the base of the penis. This arose in a very brief time span, in the absence of any physical discomfort due to the suction, and did not require any persistent mechanical manoeuvres to enhance rigidity, even starting with a completely flaccid penis. The reproducibility of the use of Alprostadil cream in association with Vacuum was then confirmed at home, to the satisfaction of the patients (3). DISCUSSION In severe ED, the simple use of a Vacuum device alone can lead to discomfort, not only physically, but also due to the continuous repeated mechanical manoeuvres needed to produce rigidity, when starting from a completely flac- cid penis. The preliminary insertion of Alprostadil cream in the ure- thra prepares the penis, to fit, quickly and safely, to the Vacuum, thanks to adequate tumescence being produced. DOI: 10.4081/aiua.2017.2.146 INTRODUCTION Severe erectile dysfunction (ED) is such a relentless health care problem that often causes an agonising ordeal to the patient and constitutes a challenge for the dedi- cated specialist who has to deal with it in daily practice. It is well-known that this condition is anything but rare, as is documented in the epidemiological literature, and that there are several causes, although not always well known or even clarifiable (1). In addition to adverse outcomes of radical pelvic surgery, these include excessive smoking, vasculopathies due to uncompensated diabetes, and even undiagnosed psy- choses. Having ascertained the ineffectiveness, intoler- ance or rejection of pharmacological treatments, pros- thetic surgery remains an option, but it may be wise and certainly feasible, to try the use of Alprostadil cream in association with Vacuum device (VITARUM) first. Mantovani1_Stesura Seveso 20/06/17 09:58 Pagina 146 147Archivio Italiano di Urologia e Andrologia 2017; 89, 2 Alprostadil and Vacuum CONCLUSIONS When left to choose between the possible inadequacy of pharmacologic treatment and the prospect of a surgical prosthesis, treatment with Alprostadil cream in associa- tion with Vacuum (VITARUM) may constitute an accept- able bridging treatment, which is feasible with a favourable cost/benefit ratio, on the arduous pathway of treating severe erectile dysfunction, where palpable cav- ernous fibrosis is absent. REFERENCES 1. Serefoglu EC, Saitz TR, Douglas LM, et al. The incidence and types of sexual dysfunction among prostate cancer patients. J Sex Med. 2012; 9(suppl 5):303-335. 2. Osorio Cabello L, Martinez Salamanca FI, Egui Rojo A, et al. Penile morphometric changes after radical prostatectomy: impact of a rehabilitation program. J Sex Med. 2012; 9(suppl 5):320. 3. Ljunggren C, Stroberg P. A clinical sexologist appears to play an important role in a penile and sexual rehabilitation program may improve the outcome of sexual function one year after prostate can- cer surgery. A prospective interventional study. J Sex Med. 2012; 9(suppl 5):319-320. Correspondence Franco Mantovani, MD mantovanifranco@yahoo.it Clinica San Giovanni Via Civitali 71, Milano, Italy Mantovani1_Stesura Seveso 20/06/17 09:58 Pagina 147